Observational studyRadiology and oncology2019

Scintigraphic load of bone disease evaluated by DASciS software as a survival predictor in metastatic castration-resistant prostate cancer patients candidates to 223RaCl treatment.

Viviana Frantellizzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.